Unither Pharmaceuticals Has Completed the Purchase of the Novartis Site Located at Butantã in São Paulo, Brazil

Unither Pharmaceuticals, the world’s leading manufacturer of sterile unit-dose products, recently acquired the Novartis plant in São Paulo, Brazil, as a new step in its industrial expansion in Brazil.

“This acquisition enables us to benefit from sterile operations in Latin America and to enlarge our offer to multidose ophthalmic containers. We are pleased to welcome the 180 people joining Unither Pharmaceuticals and bring new possibilities to our customers,” explains Eric Goupil, President of Unither Pharmaceuticals.

Unither Pharmaceuticals has a major interest in the fast-growing ophthalmology market. Thus, ongoing investments are being made, including the acquisition of this new plant in Latin America, which allows the company to manufacture ophthalmic healthcare products across four continents (Europe, Asia, North America and South America).